X chromosome, injury and infection
X chromosome, injury and infection
批准号:
8241156
负责人:
ZOLTAN SPOLARICS
金额:
$28.59万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2013-03-31
关键词:
AcuteAddressAllelesAnimalsApoptoticBiochemicalBloodBone MarrowBone Marrow CellsCell physiologyCellsClinicalComplexCritical IllnessCytokine SignalingDefense MechanismsDosage Compensation (Genetics)EndotoxemiaEnzyme-Linked Immunosorbent AssayExperimental ModelsFemaleFlow CytometryGenderGene MutationGene TargetingGenesGeneticGonadal Steroid HormonesHealthHealth StatusHistologyHomoHumanImmuneImmune responseIn VitroIndividualInfectionInfiltrationInflammationInjuryInterleukin-1InvestigationLeadLigationLinkLiverLongevityLungMAPK8 geneMeasuresMediatingMetabolicMosaicismMothersMouse StrainsMusNADPH OxidaseOrganOutcomeOxidation-ReductionPhagocytesPhenotypePhosphotransferasesPlayPopulationProductionProteinsProtocols documentationPuncture procedureRespiratory BurstRoleSepsisSignal PathwaySignal TransductionSingle Nucleotide PolymorphismSpleenSuperoxidesSystemTestingVariantX ChromosomeX Inactivationbactericidebasecytokinedimorphismimmune functionimprovedin vivokillingslink proteinmalemembernovelreceptorresponseseptic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Females as compared to males display better general health status, longer life span and improved clinical course after injury and infection. It is generally believed that the female advantage is associated with the effects of sex hormones. This project will test the question of whether the presence of cellular mosaicism of X chromosome-linked protein variants in females represents a functionally adaptive cellular system that is advantageous during the host response to infections. Cells from females carry both parental X chromosomes (maternal, Xm and paternal, Xp) whereas males carry only one X chromosome that is derived from the mother (Xm). As the result of dosage compensation and random X inactivation, half of the cells from females express proteins either from Xm or Xp, respectively. Therefore, females are cellular mosaics for X-linked polymorphic proteins. Several genes encoding key regulatory and metabolic proteins involved in the innate immune response reside on the X chromosome. The study focuses on two X-linked proteins, the first, gp91phox (Cybb) is a critical protein component of the NADPH oxidase complex that produces superoxide anion required for bacterial killing; the second, IRAK1 (IL-1 receptor associated kinase-1) is an important component of TLR-mediated cell signaling pathway. The investigations will employ experimental models of endotoxemia and sepsis utilizing mouse strains that carry genetically silenced forms of these X-linked proteins. Changes in blood and bone marrow cell compositions as well as phagocyte infiltration into lung, spleen and liver will be tested following sepsis or endotoxemia. Observations will be compared between mosaics and single-population homo/hemizygous deficient or WT animals. Alterations in cell signaling, cytokine production and redox-dependent cell functions will also be determined and compared. We hypothesize that female mosaics will display acute heterogeneous functional adaptation that will be associated with improved outcome following sepsis or endotoxemia. This will be reflected in skewed cell composition and cell activation toward mosaic subpopulations expressing the advantageous alleles together with improved bacterial killing and survival. The studies will broaden our understanding of the cellular and biochemical mechanisms responsible for immuno-modulation by X- chromosome mosaicism and gender and may open new perspectives in treating the critically ill. PUBLIC HEALTH RELEVANCE: Small differences in the genetic makeup of individuals, called single nucleotide polymorphisms (SNPs), have been shown to alter the clinical outcomes after injury and infection. In the case of X-chromosome-linked SNPs, males and females are different because females carry both parental X-chromosomes and show cellular X-chromosome mosaicism whereas males carry only one X-chromosome. The studies will test the novel hypothesis that cellular mosaicism for X-linked genetic mutations can benefit the host during the immune response to infections. Better understanding of the protecting cellular mechanisms that are in effect during septic conditions could lead to advanced protocols in treating the critically ill.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1097/ccm.0b013e3181eb9ed6
发表时间:
2010-10
期刊:
Critical care medicine
影响因子:
8.8
作者:
[Chandra R, Federici S, Haskó G, Deitch EA, Spolarics Z]
通讯作者:
Spolarics Z
In gender-based outcomes, sex hormones may be important but it is in the genes*.
在基于性别的结果中,性激素可能很重要,但它存在于基因中*。
DOI:
10.1097/ccm.0000000000000268
发表时间:
2014
期刊:
Critical care medicine
影响因子:
8.8
作者:
[Spolarics,Zoltán]
通讯作者:
Spolarics,Zoltán
DOI:
10.1007/s10753-013-9692-1
发表时间:
2013-12
期刊:
INFLAMMATION
影响因子:
5.1
作者:
[Chandra, Rachna, Federici, Stephanie, Bishwas, Tripti, Nemeth, Zoltan H., Deitch, Edwin A., Thomas, James A., Spolarics, Zoltan]
通讯作者:
Spolarics, Zoltan
X chromosome, injury and infection
-
批准号:7797529
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2009
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
X chromosome, injury and infection
-
批准号:8054855
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2009
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
Erythrocytes, immuno-modulation and G6PD deficiency
-
批准号:6938546
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2004
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
Erythrocytes, immuno-modulation and G6PD deficiency
-
批准号:7117175
-
项目类别:
-
资助金额:$27.33万
-
财政年份:2004
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
Erythrocytes, immuno-modulation and G6PD deficiency
-
批准号:6821071
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2004
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
Erythrocytes, immuno-modulation and G6PD deficiency
-
批准号:7279911
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2004
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
TRAUMA, G6PD DEFICIENCY AND SEPSIS
-
批准号:2655021
-
项目类别:
-
资助金额:$22.66万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
-
批准号:6628867
-
项目类别:
-
资助金额:$31.79万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
-
批准号:6698545
-
项目类别:
-
资助金额:$31.79万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
-
批准号:6498741
-
项目类别:
-
资助金额:$31.79万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
TRAUMA, G6PD DEFICIENCY AND SEPSIS
-
批准号:2872718
-
项目类别:
-
资助金额:$23.33万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
TRAUMA, G6PD DEFICIENCY AND SEPSIS
-
批准号:2023605
-
项目类别:
-
资助金额:$23.23万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
TRAUMA, G6PD DEFICIENCY AND SEPSIS
-
批准号:6151043
-
项目类别:
-
资助金额:$24.02万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND SEPSIS
-
批准号:6196628
-
项目类别:
-
资助金额:$30.9万
-
财政年份:1997
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
HOST DEFENSE AND THE HEPATIC PENTOSE CYCLE
-
批准号:3469019
-
项目类别:
-
资助金额:$5.82万
-
财政年份:1993
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
HOST DEFENSE AND THE HEPATIC PENTOSE CYCLE
-
批准号:3469020
-
项目类别:
-
资助金额:$3.77万
-
财政年份:1993
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
HOST DEFENSE AND THE HEPATIC PENTOSE CYCLE
-
批准号:2022679
-
项目类别:
-
资助金额:$12.0万
-
财政年份:1993
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
HOST DEFENSE AND THE HEPATIC PENTOSE CYCLE
-
批准号:2186247
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1993
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
HOST DEFENSE AND THE HEPATIC PENTOSE CYCLE
-
批准号:2186246
-
项目类别:
-
资助金额:$11.16万
-
财政年份:1993
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
HOST DEFENSE AND THE HEPATIC PENTOSE CYCLE
-
批准号:2186245
-
项目类别:
-
资助金额:$10.7万
-
财政年份:1993
-
负责人:ZOLTAN SPOLARICS
-
依托单位:
海外基金